CGCAPITAL

CGCAPITAL is a capital markets development and equity research firm for small-to-midcap companies.

[CGCAPITAL @CGCAP1TAL]

$SSKN Secures Additional $12 Million Financing with MidCap Financial https://t.co/lldIpd0K68

[CGCAPITAL @CGCAP1TAL]

$SSKN Dip Strong Buying Opportunity; Reiterate OUTPERFORM Rating, $4.00 Price Target
REPORT: https://t.co/IJp1aok7vJ
---
Rating: Outperform ... https://t.co/2zKSgflTwf

[CGCAPITAL @CGCAP1TAL]

$PDSB ASCO Review: VERSATILE-002 Data Progress With Larger Sample; Reiterate Rating & $18 PT
REPORT: https://t.co/m3IlDn9f78
---
Rating: Outperform ... https://t.co/o5JUg66bmB

[CGCAPITAL @CGCAP1TAL]

$ACHV Strong ORCA-3 Results Point Towards NDA, Alliances; Reiterate OUTPERFORM & $20 PT
REPORT: https://t.co/4z6yJLbeJl
---
Rating: Outperform ... https://t.co/G0pvxP9kht

[CGCAPITAL @CGCAP1TAL]

$SSKN 1Q Review: 2023 Should Be a Period of Material Progress; Reiterate Rating, $4.00 PT
REPORT: https://t.co/jCEN4lkai7
---
Rating: Outperform ... https://t.co/ffzN6Rtlvq

[CGCAPITAL @CGCAP1TAL]

$PDSB 1Q Review: Fully On Track for VERSATILE-003 in 4Q23; Reiterate OUTPERFORM Rating & $18 PT
REPORT: https://t.co/irhSeVSDl8
---
Rating: Outperf... https://t.co/TCdZ7nViaa

[CGCAPITAL @CGCAP1TAL]

$ACHV 1Q Review: Getting Ready For Crucial Next Steps to Commercialization; Reiterate Rating & $20 PT
REPORT: https://t.co/6vBAEOoSkc
---
Rating: O... https://t.co/yEL0fbBj92

[CGCAPITAL @CGCAP1TAL]

I just uploaded “02.02.23 Chris Bardon of MPM Capital on CNBC’s “The Exchange”” to #Vimeo: https://t.co/fKLjL7ntHu

[CGCAPITAL @CGCAP1TAL]

$SSKN 1Q Preview: Should Be Start of Exciting 2023; Reiterate OUTPERFORM Rating, $4.00 PT
REPORT: https://t.co/FcxJsrJ20B
---
Rating: Outperform ... https://t.co/BXFrJhEXlA

[CGCAPITAL @CGCAP1TAL]

$PDSB 1Q Preview: Gearing Up for the First Phase 3 Trial for PDS0101; Reiterate Rating & $18 PT
REPORT: https://t.co/iilwRcV9UX
---
Rating: Outperfo... https://t.co/YqDWOpyOHG

[CGCAPITAL @CGCAP1TAL]

$GOVX 1Q Review: Catalysts Remain Visible; Reiterating OUTPERFORM Rating, $6.00 Price Target
REPORT: https://t.co/p8AWb8LawP
---
Rating: Outperform ... https://t.co/BGA9VsbsNg

[CGCAPITAL @CGCAP1TAL]

$ECOR 1Q Review: In a Race to Cash Flow Positive; Reiterate OUTPERFORM, PT of $30
VIEW FULL REPORT: https://t.co/9q5AG9Fdwe
---
Rating: Outperform ... https://t.co/uZyUh9KjYh

[CGCAPITAL @CGCAP1TAL]

$GOVX 1Q Preview: Signs Remain Positive; Reiterating OUTPERFORM Rating, $6.00 Price TargetVIEW FULL REPORT: https://t.co/ao6hZYflt9
---
Rating: Outperf... https://t.co/75SVBuLk4a

[CGCAPITAL @CGCAP1TAL]

$ECOR 1Q Preview: Nearing Multiple Pivots; Reiterate OUTPERFORM, Price Target of $30
VIEW FULL REPORT: https://t.co/cdYpTT7NLZ
---
Rating: Outperform ... https://t.co/a8Pq1mIu5y

[CGCAPITAL @CGCAP1TAL]

$ACHV ORCA-V1 Phase II Data Highly Impressive; Reiterate OUTPERFORM Rating & $20 PT
VIEW FULL REPORT: https://t.co/NosVizq8Ni
---
Rating: Outperform ... https://t.co/HnLMpI8TI9

[CGCAPITAL @CGCAP1TAL]

$ECOR 1Q Pre-Announcement, 2023 Revenue Reiteration Show Momentum; Reiterate PT of $30
VIEW FULL REPORT: https://t.co/WIio3y9OaB
---
Rating: Outperform ... https://t.co/zpYDh3kyeH

[CGCAPITAL @CGCAP1TAL]

$SSKN 4Q Review: Upside For Q Drives Momentum Into 2023; Reiterate Rating, $4.00 PT
VIEW FULL REPORT: https://t.co/qaNhGsIC7b
---
Rating: Outperform ... https://t.co/rR9a9fZO9o

[CGCAPITAL @CGCAP1TAL]

$PDSB 4Q Review: Moving Forward with PDS0101 & VERSATILE; Reiterate Rating & $18 PT
VIEW FULL REPORT: https://t.co/jo3j3Ap4lL
---
Rating: Outperform ... https://t.co/pTvSrxmb4Y

[CGCAPITAL @CGCAP1TAL]

$GOVX 4Q Review: Good Things Happen to Those Who Wait; Reiterating OUTPERFORM Rating, $6.00 PT
VIEW FULL REPORT: https://t.co/gvXYlftFeZ
---
Rating: Outperfo... https://t.co/bx2TIcmYU7

[CGCAPITAL @CGCAP1TAL]

electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury https://t.co/whblEpcHas